• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非诺特罗及其衍生物的立体异构体与β2肾上腺素能受体结合的比较分子场分析

Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor.

作者信息

Jozwiak Krzysztof, Khalid Chakir, Tanga Mary J, Berzetei-Gurske Ilona, Jimenez Lucita, Kozocas Joseph A, Woo Anthony, Zhu Weizhong, Xiao Rui-Ping, Abernethy Darrell R, Wainer Irving W

机构信息

Department of Chemistry, Medical University of Lublin, Lublin, Poland.

出版信息

J Med Chem. 2007 Jun 14;50(12):2903-15. doi: 10.1021/jm070030d. Epub 2007 May 17.

DOI:10.1021/jm070030d
PMID:17506540
Abstract

Stereoisomers of fenoterol and six fenoterol derivatives have been synthesized and their binding affinities for the beta2 adrenergic receptor (Kibeta2-AR), the subtype selectivity relative to the beta1-AR (Kibeta1-AR/Kibeta2-AR) and their functional activities were determined. Of the 26 compounds synthesized in the study, submicromolar binding affinities were observed for (R,R)-fenoterol, the (R,R)-isomer of the p-methoxy, and (R,R)- and (R,S)-isomers of 1-naphthyl derivatives and all of these compounds were active at submicromolar concentrations in cardiomyocyte contractility tests. The Kibeta1-AR/Kibeta2-AR ratios were >40 for (R,R)-fenoterol and the (R,R)-p-methoxy and (R,S)-1-naphthyl derivatives and 14 for the (R,R)-1-napthyl derivative. The binding data was analyzed using comparative molecular field analysis (CoMFA), and the resulting model indicated that the fenoterol derivatives interacted with two separate binding sites and one steric restricted site on the pseudo-receptor and that the chirality of the second stereogenic center affected Kibeta2 and subtype selectivity.

摘要

已合成了非诺特罗的立体异构体及六种非诺特罗衍生物,并测定了它们对β2肾上腺素能受体的结合亲和力(Kibeta2-AR)、相对于β1-AR的亚型选择性(Kibeta1-AR/Kibeta2-AR)及其功能活性。在该研究中合成的26种化合物中,观察到(R,R)-非诺特罗、对甲氧基的(R,R)-异构体以及1-萘基衍生物的(R,R)-和(R,S)-异构体具有亚微摩尔级的结合亲和力,并且所有这些化合物在心肌细胞收缩性测试中在亚微摩尔浓度下均具有活性。(R,R)-非诺特罗、(R,R)-对甲氧基和(R,S)-1-萘基衍生物的Kibeta1-AR/Kibeta2-AR比值>40,(R,R)-1-萘基衍生物的该比值为14。使用比较分子场分析(CoMFA)对结合数据进行了分析,所得模型表明非诺特罗衍生物与虚拟受体上的两个独立结合位点和一个空间受限位点相互作用,并且第二个手性中心的手性影响Kibeta2和亚型选择性。

相似文献

1
Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor.非诺特罗及其衍生物的立体异构体与β2肾上腺素能受体结合的比较分子场分析
J Med Chem. 2007 Jun 14;50(12):2903-15. doi: 10.1021/jm070030d. Epub 2007 May 17.
2
Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective beta(2)-adrenergic receptor agonists.芬特罗衍生物的比较分子场分析:一个通往高选择性和有效β2-肾上腺素能受体激动剂的平台。
Bioorg Med Chem. 2010 Jan 15;18(2):728-36. doi: 10.1016/j.bmc.2009.11.062. Epub 2009 Dec 6.
3
Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol.R,R-和S,S-非诺特罗的对映体选择性分离及在线亲和色谱表征
Chirality. 2006 Nov;18(10):822-7. doi: 10.1002/chir.20317.
4
Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.通过对接和分子动力学模拟研究芬特罗对映异构体和衍生物与 β₂-肾上腺素能受体结合位点的分子相互作用。
J Mol Model. 2013 Nov;19(11):4919-30. doi: 10.1007/s00894-013-1981-y. Epub 2013 Sep 17.
5
Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes.激动剂的立体化学决定了β2-肾上腺素能受体与心肌细胞中不同G蛋白的偶联偏好。
Mol Pharmacol. 2009 Jan;75(1):158-65. doi: 10.1124/mol.108.051078. Epub 2008 Oct 7.
6
Effect of fenoterol stereochemistry on the β2 adrenergic receptor system: ligand-directed chiral recognition.芬特罗立体化学对β2 肾上腺素能受体系统的影响:配体定向手性识别。
Chirality. 2011;23 Suppl 1(Suppl 1):E1-6. doi: 10.1002/chir.20963. Epub 2011 May 26.
7
Interaction of fenoterol stereoisomers with β2-adrenoceptor-G sα fusion proteins: antagonist and agonist competition binding.非诺特罗立体异构体与β2-肾上腺素能受体-G sα融合蛋白的相互作用:拮抗剂和激动剂竞争结合
Naunyn Schmiedebergs Arch Pharmacol. 2015 May;388(5):517-24. doi: 10.1007/s00210-015-1086-5. Epub 2015 Jan 31.
8
Thermodynamics and docking of agonists to the β(2)-adrenoceptor determined using [(3)H](R,R')-4-methoxyfenoterol as the marker ligand.使用 [(3)H](R,R')-4-甲氧基苯丙醇作为标记配体测定β(2)-肾上腺素受体激动剂的热力学和对接。
Mol Pharmacol. 2012 Jun;81(6):846-54. doi: 10.1124/mol.111.077347. Epub 2012 Mar 20.
9
Comparative molecular field analysis of fenoterol derivatives interacting with an agonist-stabilized form of the β₂-adrenergic receptor.非诺特罗衍生物与β₂-肾上腺素能受体激动剂稳定形式相互作用的比较分子场分析
Bioorg Med Chem. 2014 Jan 1;22(1):234-46. doi: 10.1016/j.bmc.2013.11.030. Epub 2013 Nov 23.
10
Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.增强的G(i)信号传导选择性地消除衰竭大鼠心脏肌细胞中β2-肾上腺素能受体(AR)介导的正性肌力作用,但不消除β1-AR介导的正性肌力作用。
Circulation. 2003 Sep 30;108(13):1633-9. doi: 10.1161/01.CIR.0000087595.17277.73. Epub 2003 Sep 15.

引用本文的文献

1
Clustering of atoms relative to vector space in the Z-matrix coordinate system and 'graphical fingerprint' analysis of 3D pharmacophore structure.Z矩阵坐标系中原子相对于向量空间的聚类以及三维药效团结构的“图形指纹”分析。
Mol Divers. 2024 Dec;28(6):4087-4104. doi: 10.1007/s11030-023-10798-1. Epub 2024 Jan 28.
2
Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β adrenergic agonist.用双功能 GPR55 抑制剂和偏β肾上腺素能激动剂对胰腺癌进行代谢重编程。
Sci Rep. 2022 Mar 7;12(1):3618. doi: 10.1038/s41598-022-07600-x.
3
Structural Insights into Ligand-Receptor Interactions Involved in Biased Agonism of G-Protein Coupled Receptors.
结构洞察配体-受体相互作用涉及 G 蛋白偶联受体的偏激动作用。
Molecules. 2021 Feb 6;26(4):851. doi: 10.3390/molecules26040851.
4
Discovery of β-arrestin-biased β-adrenoceptor agonists from 2-amino-2-phenylethanol derivatives.从 2-氨基-2-苯乙醇衍生物中发现β-抑制蛋白偏向性β-肾上腺素受体激动剂。
Acta Pharmacol Sin. 2019 Aug;40(8):1095-1105. doi: 10.1038/s41401-018-0200-x. Epub 2019 Jan 14.
5
GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts.GPR55受体拮抗剂降低PANC-1胰腺癌细胞系和肿瘤异种移植模型中的糖酵解活性。
Int J Cancer. 2017 Nov 15;141(10):2131-2142. doi: 10.1002/ijc.30904. Epub 2017 Aug 7.
6
Selective GPR55 antagonism reduces chemoresistance in cancer cells.选择性GPR55拮抗作用可降低癌细胞的化疗耐药性。
Pharmacol Res. 2016 Sep;111:757-766. doi: 10.1016/j.phrs.2016.07.013. Epub 2016 Jul 14.
7
G-Protein/β-Arrestin-Linked Fluctuating Network of G-Protein-Coupled Receptors for Predicting Drug Efficacy and Bias Using Short-Term Molecular Dynamics Simulation.用于通过短期分子动力学模拟预测药物疗效和偏向性的G蛋白/β-抑制蛋白偶联的G蛋白偶联受体波动网络
PLoS One. 2016 May 17;11(5):e0155816. doi: 10.1371/journal.pone.0155816. eCollection 2016.
8
Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.(R,R')-4'-甲氧基-1-萘酚特罗对β2-肾上腺素能受体的激活可抑制黑色素瘤细胞的增殖和运动能力。
Cell Signal. 2015 May;27(5):997-1007. doi: 10.1016/j.cellsig.2015.02.012. Epub 2015 Feb 20.
9
Interaction of fenoterol stereoisomers with β2-adrenoceptor-G sα fusion proteins: antagonist and agonist competition binding.非诺特罗立体异构体与β2-肾上腺素能受体-G sα融合蛋白的相互作用:拮抗剂和激动剂竞争结合
Naunyn Schmiedebergs Arch Pharmacol. 2015 May;388(5):517-24. doi: 10.1007/s00210-015-1086-5. Epub 2015 Jan 31.
10
Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptor.受体构象研究进展:聚焦β2肾上腺素能受体探寻功能选择性构象
Br J Pharmacol. 2015 Dec;172(23):5477-88. doi: 10.1111/bph.13049. Epub 2015 Feb 27.